A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with an anti-inflammatory chemo agent called paclitaxel. “Further investigations are urgently
A federal judge in Boston accepted a plea deal from Medtronic neurovascular subsidiary ev3 in an off-label marketing case, according to court documents released at the end of January. U.S. Magistrate Judge Judith Dein granted the motion, which included the forfeiture of $6 million and an additional $11.9 million in
DU STUDIES ILIOCAVAL STENT Duplex Ultrasound improves treatment of femoro-iliocaval occlusive venous disease By Jan M. Sloves, RVT and Jose I Almeida, MD The last two decades have witnessed a great increase in stent treatment for femoro-iliocaval occlusive venous disease. We know from previous reports that the major
The American Vein & Lymphatic Society is offering a full day course on sclerotherapy featuring its new virtual reality hands-on training. The sclerotherapy course will be offered at 8 a.m. April 6 at the Sheraton Suites Chicago O’Hare in Rosemont, Illinois. Register at phleboloy.org.
By Ronald F. Bush, MD, FACS and Peggy Bush, APRN Staining (hemosiderin deposition) after sclerotherapy is not infrequent. Staining results from trapped blood that occurs after sclerotherapy injections or red cell extravasation. All vessels will clot to some degree unless methods are taken to minimize clotting at the